Search results
Fact check: Biden again falsely claims inflation was 9% when he became president
CNN via AOL· 15 hours agoIn other words, Biden’s claims make it sound like inflation is much lower today than it was when he...
Citi lifts AMC stock target to $3.20 as shares surge 175% in 2 days By Investing.com
Investing.com· 1 day agoCiti updated its model for AMC Entertainment (NYSE:AMC) Holdings Inc today as shares in the cinema...
Citi lifts AMC stock target to $3.20 as shares surge 175% in 2 days By Investing.com
Investing.com· 1 day agoCiti updated its model for AMC Entertainment (NYSE:AMC) Holdings Inc today as shares in the cinema...
Prediction: These Could Be the Best-Performing Fintech Stocks Through 2030
Motley Fool via Yahoo Finance· 4 hours agoThe COVID-19 pandemic only put a brighter spotlight on these other payment options, as much of the...
Platinum price today: Platinum is up 3.05% year to date
USA Today· 23 hours agoThe chart below shows how the spot price of platinum is trending over the year. The price of XPT/USD...
What are the new COVID FLiRT variants, and are they in Wisconsin?
Gannett via AOL· 7 days agoSymptoms may appear two to 14 days after exposure. Latest COVID guidance from the CDC In March 2024,...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 2 days agoModerna Moderna is one of the captains of a sinking ship. As a leader in the COVID-19 vaccine...
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Morningstar· 5 days ago(NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard to treat cancers, today
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19...
Earnings call: DiaMedica Therapeutics discusses Q1 progress and challenges By Investing.com
Investing.com· 2 days agoThe company is focused on ramping up site activation and participant enrollment for its ReMEDy2...